Aardvark Therapeutics (NASDAQ:AARD) Now Covered by Bank of America
Investment analysts at Bank of America began coverage on shares of Aardvark Therapeutics (NASDAQ:AARD – Get Free Report) in a note issued to investors on Monday, MarketBeat reports. The firm set a “buy” rating and a $22.00 price target on the stock. Bank of America‘s price target would indicate a potential upside of 111.13% from […]
Investment analysts at Bank of America began coverage on shares of Aardvark Therapeutics (NASDAQ:AARD – Get Free Report) in a note issued to investors on Monday, MarketBeat reports. The firm set a “buy” rating and a $22.00 price target on the stock. Bank of America‘s price target would indicate a potential upside of 111.13% from […]
